- Previous Close
0.0000 - Open
0.3700 - Bid 0.1125 x --
- Ask 0.1926 x --
- Day's Range
0.3700 - 0.3700 - 52 Week Range
0.3204 - 0.4452 - Volume
6,000 - Avg. Volume
0 - Market Cap (intraday)
153.142M - Beta (5Y Monthly) 1.36
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0600 - Earnings Date Mar 3, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
4DMedical Limited operates as a medical technology company in the United States and Australia. It engages in the medical research technology and development of a non-invasive respiratory imaging solution using four-dimensional imaging. The company also offers X-ray velocimetry lung ventilation analysis software (XV LVAS), a lung airflow imaging software, that provides lung health detail from X-Ray scans; computed tomography lung ventilation analysis software (CT LVAS), an image processing software which operates on CT scans to provide functional lung health detail; XV Scanner, a lung function scanner; and Permetium, a multi-function imaging system for pulmonary investigations. The company was incorporated in 2012 and is based in Carlton, Australia.
4dmedical.comRecent News: FDMDF
View MorePerformance Overview: FDMDF
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: FDMDF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: FDMDF
View MoreValuation Measures
Market Cap
70.53M
Enterprise Value
63.56M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
65.94
Price/Book (mrq)
3.17
Enterprise Value/Revenue
69.73
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-23.32%
Return on Equity (ttm)
-52.37%
Revenue (ttm)
5.86M
Net Income Avi to Common (ttm)
-39.54M
Diluted EPS (ttm)
-0.0600
Balance Sheet and Cash Flow
Total Cash (mrq)
15.95M
Total Debt/Equity (mrq)
8.05%
Levered Free Cash Flow (ttm)
-28.41M